Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at firstname.lastname@example.org.
30 November 2022
BMTH Team Visit Projects in Queensland and New South Wales
Recently, MTPConnect’s BioMedTech Horizons team visited Queensland and New South Wales to catch-up with five BMTH awardees for on-site visits and project progress updates. The BMTH team visited IntelliDesign and WearOptimo in Queensland, and Merunova Pty Ltd, Kunovus Technologies Pty Ltd and VenstraMedical Pty Ltd in New South Wales.
25 November 2022
MTPConnect Podcast: How Bugworks is Tackling the Superbug Challenge for World Antimicrobial Awareness Week
MTPConnect and AAMRNet are marking World Antimicrobial Awareness Week 2022 with a special podcast episode featuring a company at the forefront of antibiotic research - Bugworks!
22 November 2022
2022 Prime Minister’s Prizes for Science Announced
The 2022 Prime Minister’s Prizes for Science were announced at Parliament House on 21 November 2022 with guests from across the Australian science, research and technology community. Three scientists who founded two innovative Australian companies were celebrated in the group of 12 of the country's leading scientists.
16 November 2022
New Report from CSIRO & MTPConnect’s AAMRNet Reveals Deaths by Drug-Resistant Infections Higher than Previous Estimates
We are kicking off World Antimicrobial Awareness Week with the release of a new report ‘Antimicrobial Resistance (AMR) Impact Report: How big is Australia’s AMR threat?’ Not surprisingly, it’s much higher than what was previously thought: in the thousands rather than hundreds.
15 November 2022
MTPConnect Announces 16 REDI Fellowships in Sought After Industry Roles
MTPConnect is pleased to announce that 16 highly skilled Australian researchers, clinicians and professionals from the medical technology, biotechnology and pharmaceutical sector have secured sought-after industry placements under the REDI (Researcher Exchange and Development within Industry) Fellowship program.
10 November 2022
In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in October
Check out what MTPConnect got up to in October!
07 November 2022
ANDHealth launches WA Connected Health Commercialisation Initiative with our WA Life Sciences Innovation Hub
ANDHealth, Australia’s leading digital health commercialisation organisation, has launched the WA Connected Health Commercialisation Initiative, in collaboration with our WA Life Sciences Innovation Hub, a partnership with MTPConnect, the WA Government Department of Jobs, Tourism, Science and Industry, and the University of Western Australia.
03 November 2022
Board Renewal at MTPConnect – Search for New Chair to Build Next Growth Phase
As part of its commitment to good corporate governance, MTPConnect has commenced a Board renewal process to recruit a new chair.
03 November 2022
National Diagnostic Action Plan Preliminary Findings Published
MTPConnect has been engaged by the Department of Industry, Science and Resources (DISR) to develop a National Action Plan for establishing end-to-end sovereign manufacturing capability for diagnostic products in Australia. The project is mid-way to be being delivered in partnership with Pathology Technology Australia (PTA) and supported by HTANALYSTS.
02 November 2022
MTPConnect podcast: CSIRO Kick-Starts R&D for Start-ups like Singular Health to Commercialise Innovations
Five years on, CSIRO’s Kick-Start program continues to support early-stage start-ups and small businesses facing barriers through R&D support.
Over 200 companies have benefited from Kick-Start support by having access to CSIRO’s research and capability through an innovative voucher scheme.
31 October 2022
Vast Bioscience – solving the growing post-surgical pain conundrum with 3D Drug Discovery Technology
Pain is a debilitating condition and over the past few decades, escalating use of opioid therapeutics to manage pain has become a cause of concern in many countries, including Australia. Brisbane-based biotech company Vast Bioscience Pty Ltd aims to offer the pharmaceutical industry a unique opportunity to develop innovative drugs with superior potency, target selectivity and safety to help treat pain.
28 October 2022
Team Australia Wraps Up the MedTech Conference in Boston
The MTPConnect team and the 18 companies in the Australian delegation are wrapping up a week of activities at the 2022 MedTech Conference in Boston. Check out some of the top level opportunities that MTPConnect organised for these promising medtech companies.
26 October 2022
REDI Fellow Explores AI’s Powerful Role in Pathology
In Associate Professor Ewan Millar’s vision for the future of pathology in NSW, the skills, experience and expertise of Anatomical Pathologists is backed by powerful technology. A/Prof. Millar from NSW Health Pathology is currently undertaking a REDI Fellowship with Paige, a New York based global leader in AI-based diagnostic pathology software. Read about his work with Paige and his REDI Fellowship experience - an unrivalled opportunity and his dream role.
26 October 2022
MTPConnect cements US medtech links through MoU with influential Medical Alley Association at the 2022 MedTech Conference
MTPConnect and the Medical Alley Association of Minnesota have committed to working closely together to support the growth of medtech companies with the signing today of a Memorandum of Understanding. The MoU was signed at the 2022 MedTech Conference in Boston by MTPConnect Chief Executive Officer Stuart Dignam and Medical Alley Association’s Vice President of Intelligence, Frank Jaskulke.
25 October 2022
New funding for The Bridge Program to continue its successful pharma commercialisation training in 2023
The Bridge Program is proud to announce that MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative will be the new sponsor of its successful Australian pharmaceutical commercialisation training program delivered by Queensland University of Technology (QUT).